Passumpsic Savings Bank bought a new position in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 11,649 shares of the health services provider's stock, valued at approximately $2,090,000.
Other institutional investors have also recently bought and sold shares of the company. Hussman Strategic Advisors Inc. increased its position in shares of Universal Health Services by 300.0% during the 4th quarter. Hussman Strategic Advisors Inc. now owns 16,800 shares of the health services provider's stock worth $3,014,000 after purchasing an additional 12,600 shares during the last quarter. Concurrent Investment Advisors LLC acquired a new stake in Universal Health Services in the fourth quarter valued at $255,000. Handelsbanken Fonder AB increased its stake in shares of Universal Health Services by 20.5% during the 4th quarter. Handelsbanken Fonder AB now owns 13,500 shares of the health services provider's stock worth $2,422,000 after purchasing an additional 2,300 shares during the last quarter. Ieq Capital LLC raised its holdings in shares of Universal Health Services by 420.4% in the 4th quarter. Ieq Capital LLC now owns 14,228 shares of the health services provider's stock valued at $2,553,000 after purchasing an additional 11,494 shares during the period. Finally, Abacus Planning Group Inc. lifted its stake in Universal Health Services by 175.6% in the 4th quarter. Abacus Planning Group Inc. now owns 2,792 shares of the health services provider's stock valued at $501,000 after purchasing an additional 1,779 shares during the last quarter. Institutional investors own 86.05% of the company's stock.
Insider Buying and Selling at Universal Health Services
In related news, Director Maria Ruderman Singer sold 1,614 shares of the company's stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $191.15, for a total transaction of $308,516.10. Following the sale, the director now owns 5,879 shares in the company, valued at $1,123,770.85. This represents a 21.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 16.10% of the company's stock.
Wall Street Analysts Forecast Growth
UHS has been the topic of several research analyst reports. The Goldman Sachs Group lowered Universal Health Services from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $228.00 to $198.00 in a research note on Monday, December 16th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $226.00 price target on shares of Universal Health Services in a research note on Tuesday, December 17th. StockNews.com downgraded Universal Health Services from a "strong-buy" rating to a "buy" rating in a research report on Saturday, November 9th. TD Cowen reduced their price target on Universal Health Services from $275.00 to $251.00 and set a "buy" rating for the company in a research note on Tuesday, November 26th. Finally, Cantor Fitzgerald upgraded Universal Health Services from a "neutral" rating to an "overweight" rating in a research report on Monday, February 3rd. Six analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Universal Health Services currently has an average rating of "Moderate Buy" and an average price target of $226.14.
View Our Latest Analysis on UHS
Universal Health Services Price Performance
Shares of UHS stock traded down $9.90 during trading hours on Wednesday, reaching $179.11. The company's stock had a trading volume of 1,149,373 shares, compared to its average volume of 557,370. Universal Health Services, Inc. has a fifty-two week low of $152.68 and a fifty-two week high of $243.25. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69. The firm's 50 day simple moving average is $184.35 and its 200-day simple moving average is $205.64. The company has a market capitalization of $11.82 billion, a price-to-earnings ratio of 11.91, a PEG ratio of 0.53 and a beta of 1.30.
Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported $4.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.71. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. Sell-side analysts forecast that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.
Universal Health Services Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.45%. Universal Health Services's dividend payout ratio (DPR) is presently 5.32%.
Universal Health Services Company Profile
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
See Also

Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.